Our technology

Using engineered cells, we can screen canonical libraries of small molecules, or our proprietary libraries of >10 billion DNA encoded peptides and macrocycles to identify compounds that can either disrupt a protein-protein interaction, or bridge an interaction.

Since the technology relies on a cell-based functional readout, we are able to discover compounds that work through either competitive or allosteric mechanisms. ​We can also engineer multiple readouts into one cell for complex functional modulation of difficult targets.